Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2011-12-31 Ahn Mark J President & CEO Other acquisition +31,289 $0.40 $13K 61,289
2011-12-07 Lee Kwang Principal Accounting Officer Purchase +5,000 $0.60 $3K 5,000
2011-12-07 Ahn Mark J President & CEO Purchase +10,000 $0.66 $7K 20,000
2011-09-27 GALLIKER STEPHEN S Director Grant or award · Stock Option (right to buy) +50,000 50,000
2011-09-27 Chin Richard Director Grant or award · Stock Option (right to buy) +25,000 25,000
2011-09-27 KRIEGSMAN STEVEN A Director Grant or award · Stock Option (right to buy) +200,000 200,000
2011-09-27 Hillsberg Sanford Director Grant or award · Stock Option (right to buy) +200,000 200,000
2011-09-27 Nisi Rudolph Director Grant or award · Stock Option (right to buy) +100,000 100,000
2011-09-24 Pavco Pamela Former VP Pharma Development Grant or award · Stock Option (right to buy) +150,000 150,000
2011-09-24 Khvorova Anastasia Former CSO Grant or award +76,923 137,482
2011-09-07 SCHWARTZ MARK W. EVP Chief Operating Officer Grant or award · Stock Option (right to buy) +250,000 250,000
2011-04-20 Ahn Mark J President and CEO Purchase +10,000 $0.95 $10K 10,000
2011-04-13 SCHWARTZ MARK W. EVP, Chief Operating Officer Grant or award +330,872 330,872
2011-04-13 SCHWARTZ MARK W. EVP Chief Operating Officer Grant or award +337,661 337,661
2011-04-13 SCHWARTZ MARK W. EVP Chief Operating Officer Grant or award · Common Stock +40,000 40,000
2011-04-13 Kennedy Robert Eugene Vice President and CFO Grant or award +374,288 374,288
2011-04-13 Kennedy Robert Eugene Vice President and CFO Grant or award +2,430 376,718
2011-04-13 Kennedy Robert Eugene Vice President and CFO Grant or award +2,576 379,294
2011-04-13 Kennedy Robert Eugene Vice President and CFO Grant or award · Stock Option +30,000 30,000
2011-04-13 Hillsberg Sanford Director Grant or award +120,838 126,838

Page 20 of 29 · 580 trades